Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico…
Immuno-oncology
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Immuno-oncology
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Acquisitions
X-Vax Technology Appoints Isaac Blech as Vice Chairman to its Board…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Immuno-oncology
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Immuno-oncology
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Clinical
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement…
Clinical
Medicine Supply Notification: Ketotifen 1mg/5ml elixir (Zaditen) – FirstWord Pharma
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Sanofi eyes acquisitions in US, including Principia Biopharma: report – FirstWord…
Clinical
Lilly’s mirikizumab superior to Novartis’ Cosentyx in psoriasis study – FirstWord…
Immuno-oncology
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Immuno-oncology
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Home
Therapy areas
Immuno-oncology
Immuno-oncology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-oncology
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor) Research – FirstWord Pharma
Firstwordpharma News
-
July 18, 2020
Immuno-oncology
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in Ovarian Cancer in China – FirstWord Pharma
Immuno-oncology
Success in Live Births Outcomes After Cancer-Related Fertility Preservation: Presented at ESHRE – FirstWord Pharma
Immuno-oncology
Biotech Company Cerule Appoints Triple Board Certified, US Patent Holding Doctor Stanley Jacobs, MD, to Their Medical Advisory Board
Immuno-oncology
Glympse Bio Secures $46.7 Million to Advance NASH Biosensor Program
Immuno-oncology
ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical...
Biospace News
-
July 15, 2020
0
Immuno-oncology
Glympse Bio Announces $46.7 Million Series B Financing
Biospace News
-
July 15, 2020
0
Immuno-oncology
Sanofi And MD Anderson Announce Strategic Collaboration To Accelerate Oncology Research...
-
July 14, 2020
0
Immuno-oncology
Citius Pharmaceuticals Brings on Myron S. Czuczman, M.D. as Chief Medical...
Biospace News
-
July 14, 2020
0
Immuno-oncology
FDA staff say ocular toxicity tied to GSK’s belantamab mafodotin may...
Firstwordpharma News
-
July 12, 2020
0
1
2
3
...
66
Page 1 of 66
- Advertisement -
MOST POPULAR
Bayer donates $130,000 to 13 domestic violence shelters through new Grants...
February 13, 2019
Novartis ends development of fevipiprant in asthma after further late-stage study...
December 16, 2019
On World Sight Day, Allergan Launches National Campaign to Raise Awareness...
October 10, 2019
Bellicum Pharmaceuticals Announces Presentation on CAR-NK Cell Program at SITC 2019
October 31, 2019
Load more
HOT NEWS
Clinical
BioMarin’s Biologics License Application for Valoctocogene Roxaparvovec Accepted for Priority Review...
Commercial
Nordic Nanovector ASA: Invitation to First Quarter 2019 Results Presentation and...
Deals
Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development...
Deals
NewLink Genetics Announces Exclusive Worldwide License Agreement with Ellipses Pharma for...
